🧠 Neflamapimod has received ILAP designation in the UK for dementia with Lewy bodies, an important milestone that could help accelerate patient access to innovative treatments.
🎥 Hear Jacqui Cannon discuss what this means for patients.
👉 Watch now: ow.ly/2KXX50ZwT6O
@lewybodysociety.bsky.social